Lv53
1120 积分 2024-02-26 加入
Drug development of MET inhibitors: targeting oncogene addiction and expedience
1天前
待确认
How does p53 work? Regulation by the intrinsically disordered domains
5天前
已完结
c-Met: structure, functions and potential for therapeutic inhibition
19天前
已完结
Cell-free DNA Fragmentomics Assay to Discriminate the Malignancy of Breast Nodules and Evaluate Treatment Response
20天前
已完结
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
22天前
已完结
EGFR Tyrosine Kinase Inhibitors in Lung Cancer: An Evolving Story
1个月前
已完结
EGFR Mutations and Lung Cancer
1个月前
已完结
Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma
2个月前
已完结
Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA
2个月前
已完结
ctDNA quantification improves estimation of outcomes in patients with high-grade osteosarcoma: a translational study from the OS2006 trial
3个月前
已完结
皖公网安备34019202002308
